CAPÃTULO IV Hipertrigliceridemias secundarias - Sociedad ...

More documents

Recommendations

Info

Hipertrigliceridemias secundarias Bibliografía 1. Brunzell JD, Failor RA. Diagnosis and treatment of dislipidemias. En: Dale DC, editor.ACP medicine 2006 edition.Vol. 1. New York:WebMD; 2006. 2. Hopkins PN, Heiss G, Ellison RC, et al. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 2003;108:519-23. 3. Hodis HN, Mack WJ, Krauss RM, et al. Pathophysiology of triglyceriderich lipoproteins in atherothrombosis: clinical aspects. Clin. Cardiol. 1999;22:1161-77. 4. Yuan G,Al-Shalid KZ, Engele RA. Hipertrigliceridemia: its etiology, effects and treatment. CMAJ 2007;176:1113-20. 5. Brunzell JD, Deeb SS. Familial lipoprotein lipase deficiency and hepatic lipase deficiency. En: Scriver CR, Beaudet AI, Sly WD,Valle D, editors.The metabolic and molecular bases of inherit disease. 8th ed.Vol. 3. New York: McGraw-Hill; 2000. p. 2789-816. 6. Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperalipoprotein B; small, dense LDL) in men? Circulation 2000;102:179-84. 7. Pollex RL, Hegele RA. Genetic determinants of the metabolic syndrome. Nat Clin Pract Cardiovasc Med 2006;3:482-9. 8. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97. 9. Cía Gómez P, Cía Blasco P.Asociación de factores de riesgo (síndromes metabólicos). En:. Millán Núñez-Cortes J, editor. Medicina Cardiovascular. Barcelona: Masson; 2005;10:471-84. 10. Maher VM, Brown BG, Marcovina SM, Hillger LA, Zhao XQ, Albers JJ. Effectes of lowering elevated LDL coleterol on the cardiovascular risk of lipoprotein(a). JAMA 1995;274:1771-4. 11. Brunzell JD. Hypertriglyceridemia. N Engl J Med 2007;6:1009-17. 12. Criqui MH, Heiss G, Cohn R, et al. Plasma triglyceride and mortality from coronary heart disease. N. engl J Med 1993;328:1220-5. 93
PROTOCOLOS HIPERTRIGLICERIDEMIAS 13. Hokanson JE,Austin MA. Plasma trigliceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metanalisis of population-based prospective studies. J Cardiovasc Risk 1996;3:312-9. 14. Zilversmit DB. Atherogenesis: a postprandrial phenomenon. Circulation 1979; 60: 473-85. 15. Calza L, Manfredi R, Chiodo F. Dyslipaemia associated with antiretroviral therapy in HIV-infected patientes. J Antimicriob Chemother 2004;53:10- 4. 16. Tarricone I, Casoria M, Gozzi BF, et al. Metabolic risk factor profile associated with use uf second generation antipsychotics: a cross sectional study in a community mental health centre. BMC Psychiatry 2006;6:11. 17. Álvarez-Sala LA, Muñoz Rivas N, Caño Hortoneda M,Teigell García L. Trastornos de las lipoproteínas. En: Perezagua Clamagirand C, editor. Tratado de Medicina Interna (II). Madrid:Ariel; 2005. p. 2574-8. 94
Page 1 and 2: PROTOCOLOS HIPERTRIGLICERIDEMIAS So
Page 3 and 4: PROTOCOLOS HIPERTRIGLICERIDEMIAS Ad
Page 5 and 6: PROTOCOLOS HIPERTRIGLICERIDEMIAS Ta
Page 7 and 8: PROTOCOLOS HIPERTRIGLICERIDEMIAS do
Page 9 and 10: PROTOCOLOS HIPERTRIGLICERIDEMIAS Ta
Page 11 and 12: PROTOCOLOS HIPERTRIGLICERIDEMIAS Hi
Page 13 and 14: PROTOCOLOS HIPERTRIGLICERIDEMIAS He
Page 15: PROTOCOLOS HIPERTRIGLICERIDEMIAS Ha

CAPÃTULO IV Hipertrigliceridemias secundarias - Sociedad ...

Create successful ePaper yourself

Delete template?

Save as template?

CAPÃTULO IV Hipertrigliceridemias secundarias - Sociedad ...